C41H45N13O3S — CID 156836589
7-[5-[5-[4-[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylamino)-2-pyridinyl]pyrrolo[1,2-b]pyridazine-3-carbonitrile (PubChem CID 156836589) has the molecular formula C41H45N13O3S and a molecular weight of 799.97 g/mol. Its IUPAC name is 7-[5-[5-[4-[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylamino)-2-pyridinyl]pyrrolo[1,2-b]pyridazine-3-carbonitrile.
| Compound Name | 7-[5-[5-[4-[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylamino)-2-pyridinyl]pyrrolo[1,2-b]pyridazine-3-carbonitrile |
|---|---|
| PubChem CID | 156836589 |
| Molecular Formula | C41H45N13O3S |
| Molecular Weight | 799.97 g/mol |
| Exact Mass | 799.35 |
| IUPAC Name | 7-[5-[5-[4-[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylamino)-2-pyridinyl]pyrrolo[1,2-b]pyridazine-3-carbonitrile |
| SMILES | CC(C)Nc1cc(-c2ccc3cc(C#N)cnn23)ncc1-c1nnc(N2CCN(CC3CCN(c4cccc5c4n(C)c(=O)n5C4CCC(=O)NC4=O)CC3)CC2)s1 |
| InChI | InChI=1S/C41H45N13O3S/c1-25(2)45-30-20-31(32-8-7-28-19-27(21-42)22-44-54(28)32)43-23-29(30)39-47-48-40(58-39)52-17-15-50(16-18-52)24-26-11-13-51(14-12-26)33-5-4-6-34-37(33)49(3)41(57)53(34)35-9-10-36(55)46-38(35)56/h4-8,19-20,22-23,25-26,35H,9-18,24H2,1-3H3,(H,43,45)(H,46,55,56) |
| InChIKey | SWMPTZFMZXWOOV-UHFFFAOYSA-N |
| XLogP | 4.28 |
| TPSA | 174.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 799.97 |
| LogP ≤ 5 | 4.28 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 16 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|